Increasing the Dose Intensity of Chemotherapy by Means of Granulocyte-colony Stimulating Factor (G-CSF) Support in the Treatment of Small Cell Lung Cancer (SCLC)

By Girling D.J.   Thatcher N.   Clark P.I.   Stephens R.J.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1263-1263

Elsevier

Access to resources Recommend Favorite

Phase II Study of Intensive CEV (Carboplatin, Epirubicin and VP-16) Plus G-CSF (Granulocyte-colony Stimulating Factor) in Extensive Small Cell Lung Cancer

By Gridelli C.   Perrone F.   D'Aprile M.   Rossi A.   Palmeri S.   Curcio C.   Veltri E.   Ianniello G.   Lorusso V.   Palmieri G.   Rinaldi L.   De Placido S.   Gallo C.   Bianco A.R.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2424-2426

Elsevier

Access to resources Recommend Favorite

The Feasibility of Using Glycosylated Recombinant Human Granulocyte Colony-stimulating Factor (G-CSF) to Increase the Planned Dose Intensity of Doxorubicin, Cyclophosphamide and Etoposide (ACE) in the Treatment of Small Cell Lung Cancer

By Thatcher N.   Anderson H.   Bleehen N.M.   Girling D.J.   Lallemand G.   Machin D.   Stephens R.J.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 152-156

Elsevier

Access to resources Recommend Favorite

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

By Haim Nissim   Shulman Katerina   Goldberg Hadassah   Tsalic Medy  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 229-232

Humana Press, Inc

Access to resources Recommend Favorite

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

By Lalami Y.   Paesmans M.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite